A class action over alleged botched cosmetic surgeries can drop claims against one surgeon, but the doctor will remain a party so other defendants can point the finger at him.
A class action against Sydney doctor Daniel Lanzer and several of his associates over alleged botched cosmetic surgeries wants to drop its claims against one doctor, but other defendants have taken issue.
A judge has signed off on the eighth version of a class action against Sydney doctor Daniel Lanzer and several of his associates over allegedly negligent cosmetic surgeries.
Sydney-based plastic surgeon Daniel Lanzer and several of his associates have objected to a class action’s eighth attempt at getting its claims over allegedly negligent cosmetic procedures right, saying the plaintiffs were engaged in a “continuing cycle of propagating versions” of their case.
A judge has railed against the parties in a class action against Sydney-based plastic surgeon Daniel Lanzer and four of his associates for “repeated failure to comply with court orders” in the two-year-old case.
A judge has directed a class action on behalf of 1,000 patients of Sydney-based plastic surgeon Daniel Lanzer and four of his associates to have another go at articulating claims that Lanzer’s clinic should be liable for allegedly ‘horrific’ complications.
The High Court has found that three asset-based lenders behaved unconscionably when they enforced thir rights under a $1.2 million loan made to a vulnerable consumer secured by a mortgage over his properties.
Over-the-counter derivative issuers AGM Markets, OT Markets and Oxifin Tech have been ordered to pay a total of $75 million in penalties after a ruling that they engaged in unconscionable conduct causing losses of over $30 million to unsophisticated investors seeking what a judge called “financial heroin hits”.
An appeals court has dismissed a second bid by lawyer Alex Elliott to have the judge overseeing the Banksia class action disqualified from hearing claims that he, like his late father, was party to an alleged fraudulent scheme in running the litigation.
ASIC has notched up a win against derivative issuer AGM Markets and two of its authorised representatives, with a court finding they engaged in misleading, deceptive and unconscionable conduct that caused investor losses of over $30 million.